Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Hypermobility Healthy Individuals

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04208022
Recruitment Status : Recruiting
First Posted : December 23, 2019
Last Update Posted : February 10, 2020
Sponsor:
Collaborator:
Saglik Bilimleri Universitesi
Information provided by (Responsible Party):
Gülşah Karaca, Istanbul Kültür University

Brief Summary:
Benign Joint Hypermobility Syndrome is a hereditary connective tissue problem characterized by the emergence of multiple musculoskeletal problems in hypermobile individuals without a systemic rheumatologic disease. Studies have shown that hypermobility may also affect lung function. Playing wind instruments requires tiring breathing activity. The effect of wind instrument on lung function and how it affects lung function is a highly controversial issue. Given the distribution and importance of collagen tissue in the body, multiple effects of hypermobility are inevitable. The aim of this study was to evaluate the presence of hypermobility in young healthy individuals; The aim of the study is to investigate the effects of hypermobility on the cardiovascular system and to provide training to the participants regarding the findings.The aim of this study is to investigate the relationship of hypermobility with respiratory functions in professional hypermobile musicians and to compare this relationship with healthy hypermobile individuals who are not engaged in music.

Condition or disease Intervention/treatment
Respiratory Problems Other: Respiratory evaluation

Detailed Description:
Sociodemographic data and musical backgrounds of all cases will be recorded. In accordance with the objectives, erm Upper Extremity Hypermobility Assessment Questionnaire "was used for hypermobility, pulmonary function test, respiratory and oral pressure measurement and respiratory muscle strength. The George Respiratory Questionnaire (SGRQ) will be used to assess the quality of life associated with respiration and the risk of asthma with the ile European Respiratory Health Survey, Phase 1 "questionnaire.We believe that the effects of hypermobility on pulmonary functions in healthy individuals will be clarified if this study takes place.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Other
Time Perspective: Other
Official Title: The Effect of Hypermobility on Respiratory Functions in Musicians Playing Wind Instruments and Healthy Individuals Not Involved in Music
Actual Study Start Date : August 1, 2019
Estimated Primary Completion Date : December 30, 2020
Estimated Study Completion Date : December 30, 2020

Group/Cohort Intervention/treatment
Healthy Musician
At least 15 hypermobile musicians and at least 15 non-hypermobile musicians will be included in the study.
Other: Respiratory evaluation
Hypermobility and Respiratory evaluation

Healthy Individuals
The study will include at least 15 healthy non-hypermobile individuals who do not deal with music and at least 15 healthy hypermobile individuals who do not deal with music.
Other: Respiratory evaluation
Hypermobility and Respiratory evaluation




Primary Outcome Measures :
  1. The Upper Limb Hypermobility Assessment Tool [ Time Frame: 10 minutes ]
    Hypermobility

  2. St. George Respiratory Questionnaire [ Time Frame: 5 minutes ]
    respiratory quality

  3. European Respiratory Health Survey, Phase 1 [ Time Frame: 5 minutes ]
    assess the risk of asthma

  4. Respiratory function test [ Time Frame: 15minutes ]
    FEV1,FVC

  5. mouth pressure measurement [ Time Frame: 15minutes ]
    MIP, MEP


Secondary Outcome Measures :
  1. Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians [ Time Frame: 10 minutes ]
    Pain



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
The musicians who meet the criteria for inclusion in the study and who play the wind instrument who agree to voluntarily participate in the study and healthy individuals who are not interested in music will be included.
Criteria

Inclusion Criteria for Musicians

Be between 18-35 years Playing wind instruments for at least one year For the hypermobile subgroup; Obtaining ≥7 / 12 points from the Upper Extremity Hypermobility Assessment Questionnaire

Inclusion Criteria for Healthy Individuals Not Engaged in Music

Be between 18-35 years No diagnosed health problems For the hypermobile subgroup; Obtaining ≥7 / 12 points from the Upper Extremity Hypermobility Assessment Questionnaire

Exclusion Criteria for Musicians

Having a specific respiratory problem diagnosed Symptoms of nerve impingement in upper extremity Smoking

Exclusion Criteria for Healthy Individuals Not Engaged in Music

Symptoms of nerve impingement in upper extremity Smoking


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04208022


Contacts
Layout table for location contacts
Contact: Karaca 05468744530 karacagulsah92@gmail.com

Locations
Layout table for location information
Turkey
Istanbul Kultur University Recruiting
Istanbul, E5 Highway Bakırköy, İstanbul, Turkey, 34158
Contact: Karaca    0546 874 4530    karacagulsah92@gmail.com   
Principal Investigator: Esra Pehlivan, Asst.Prof.Dr         
Sponsors and Collaborators
Istanbul Kültür University
Saglik Bilimleri Universitesi
Investigators
Layout table for investigator information
Principal Investigator: Esra Pehlivan, Asst.Prof.Dr Saglik Bilimleri Universitesi
Principal Investigator: Gulsah Karaca, Researcher Istanbul Kültür University
Layout table for additonal information
Responsible Party: Gülşah Karaca, Research Assistant, Istanbul Kültür University
ClinicalTrials.gov Identifier: NCT04208022    
Other Study ID Numbers: IstanbulKulturU
First Posted: December 23, 2019    Key Record Dates
Last Update Posted: February 10, 2020
Last Verified: February 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Gülşah Karaca, Istanbul Kültür University:
Musicians
Respiratory
Hypermobility